Glenmark Pharmaceuticals Limited has received final approval from the United States Food and Drug Administration
Glenmark Pharmaceuticals Inc, USA, has announced plans to launch Potassium Phosphates Injection USP in multiple
Glenmark Pharmaceuticals Inc, USA, has announced the launch of Epinephrine Injection USP, 30 mg/30 mL
Glenmark Pharmaceuticals Ltd., a research-driven global pharmaceutical company, has rolled out Nebzmart® GFB Smartules® and
Glenmark Pharmaceuticals reported a significant widening of its loss for the quarter ended March 31,
Glenmark Pharmaceuticals Ltd announced today that it has received final approval from the US Food
Glenmark Pharmaceuticals has achieved a significant milestone with the receipt of approval from the US
Glenmark Pharmaceuticals has achieved a significant milestone with the receipt of approval from the US
Glenmark Pharmaceuticals has achieved a significant milestone with the receipt of approval from the US
NULL
